Raymond James analyst Jayson Bedford lowered the price target on Edwards Lifesciences (NYSE: EW) to $200.00 (from $210.00) while maintaining a Outperform rating.

Analyst PT Change

Edwards Lifesciences (EW) PT Raised to $200 at StifelApril 24, 2019 8:36 AM Edwards Lifesciences (EW) PT Raised to $184 at Deutsche BankApril 24, 2019 7:14 AM Edwards Lifesciences (EW) PT Raised to $186 at RBC CapitalApril 24, 2019 6:39 AM Form 8-K Edwards Lifesciences For: Apr 23April 23, 2019 4:30 PM Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Raises OutlookApril 23, 2019 4:16 PM Edwards Lifesciences Reports First Quarter ResultsApril 23, 2019 4:15 PM